Joshua J. Ofman M.D., M.S.H.S
Dr. Ofman is Responsible for directing Amgen activities related to ensuring that Amgen products have a compelling value proposition and obtain market access from payers in each market, worldwide. These activities include global pricing, market access planning, global health economics, international government affairs, and health policy.
Dr. Ofman completed his undergraduate degree in the history and philosophy of science at University of California, Berkeley before completing his medical education at UC Irvine School of Medicine. He then completed his internship and residency in internal medicine at UCLA Medical Center. Following his residency, Dr. Ofman completed a two-year VA/UCLA/RAND fellowship in health services research, during which time he received his Masters of Science in Health Services (MSHS) degree from the UCLA School of Public Health. Dr. Ofman also completed a fellowship in gastroenterology at the UCLA integrated training program in digestive diseases. His research interests include health economics and technology assessment, program evaluation and health policy analysis, and he is widely published in these disciplines.
Dr. Ofman has served on several advisory boards for the American Gastroenterological Association, the American College of Physicians Clinical Efficacy Assessment Subcommittee, and is on the editorial board of the American Journal of Managed Care.
Dr. Ofman currently represents Amgen on the Board of Directors of California Healthcare Institute (CHI) and National Pharmaceutical Council (NPC).
Prior to joining Amgen in 2003 as head of US Health Economics and Outcomes Research, Dr. Ofman was a member of the academic faculty in the Department of Medicine and Health Services Research, UCLA School of Medicine, Cedars-Sinai Medical Center. In this capacity, Dr. Ofman worked extensively with AHRQ’s Southern California Evidence-Based Practice Center and taught courses on the principles of evidence-based medicine. Dr. Ofman also served as the Senior Vice President of Zynx Health Inc., a consulting company focused on evidence-based clinical information for quality improvement, and reimbursement and health economics strategy for life sciences companies.